Europe Investment Report 2024 — Competitiveness Becomes the Frame

Something changed in 2024 that was not a market event: Europe's structural economic constraints stopped being a specialist topic and became the organising frame of policy.

The specific arguments were not new. The growth-stage capital gap, the fragmentation cost, the energy cost differential, the absence of large European technology companies, the regulatory burden on entrants, the incomplete capital market — every one of these appears in earlier reports in this sequence, and most had been made by analysts for years.

What changed was their status. They moved from being observations made by people outside the policy process to being the explicit premise of it. Competitiveness became the frame through which European economic policy was discussed, at the highest level, with the diagnosis substantially matching what the analysis had been saying.

This matters and it is easy to overstate why.

Why it matters: as the Europe Venture Capital Report 2023 concludes, Europe's growth-stage gap is sustained by rules — insurance capital charges, pension architecture, fragmented securities regulation, listing requirements. Rules change through political processes, and a political process requires the problem to be on the agenda. It was not, and now it is.

Why it is easy to overstate: recognition is the first step of many, and every subsequent step is harder. The rules in question are largely national competences. Changing them requires member states to cede authority in areas — taxation, insolvency, securities supervision, pension policy — where they have consistently declined to. The capital markets agenda has been discussed for over a decade without decisive progress, which is informative about the difficulty rather than about the analysis.

Why recognition is the necessary first step

The relationship between diagnosis and change is worth setting out, because "everyone agrees on the problem" is frequently mistaken for progress.

What recognition provides:

• A shared premise. Negotiations that begin from an agreed diagnosis are different from ones where the diagnosis is contested. The argument moves from whether there is a problem to what to do about it.
• Political cover. A minister proposing a change that transfers national competence needs a reason. An official diagnosis is one.
• Sequencing. A problem on the agenda gets a workstream, a timeline and a review point. One that is not gets none of these.
• Measurement. An official frame generates official indicators, which makes progress or its absence visible.

What recognition does not provide:

• Agreement on remedies. Members with different pension systems, different industrial bases and different fiscal positions have genuinely different interests in each proposed change.
• Willingness to cede competence. The specific obstacles are national. Removing them means member states giving up authority, which they have consistently resisted where the benefit is diffuse and the cost concentrated.
• A timeline. The capital markets agenda's decade-plus history is the relevant evidence.
• Resolution of the trade-offs. Some remedies conflict with other objectives that also have constituencies.

A diagnosis moves a problem from the analysis stage to the negotiation stage. That is genuine progress and it is the point at which the difficulty begins rather than the point at which it ends.

The honest position for an investor is that 2024's recognition raises the probability of structural change from very low to merely low, over a horizon measured in years. That is worth updating on and it is not worth underwriting.

Why the capital markets question is political, not technical

The obstacles to a single European capital market are frequently described as technical. They are not, and the distinction determines how likely they are to be removed.

What a genuine single capital market requires:

• Harmonised or mutually-recognised securities regulation, so an issuer can raise across the union without twenty-seven processes.
• Harmonised insolvency law, so a creditor's position is predictable regardless of where the borrower is. This matters enormously for anyone lending across borders.
• Consistent taxation of investment income, so cross-border holding is not penalised.
• Consolidated supervision, so a single authority oversees pan-European activity.
• Comparable pension and savings frameworks, so retail capital can flow into capital markets across the union.

Every one of these is a national competence. They are not technical standards that can be agreed by experts; they are areas where member states retain authority and have declined to transfer it.

Why the resistance is rational from each member's perspective:

• Insolvency law encodes national policy choices about creditor and debtor rights, employee protection and business rescue. These reflect genuinely different social preferences.
• Taxation is the core of fiscal sovereignty and is generally subject to unanimity, which gives every member a veto.
• Supervision transfers authority from national regulators to a union body, with domestic institutional and employment consequences.
• The benefits are diffuse and the costs concentrated. A deeper capital market benefits everyone slightly and diffusely; ceding a competence costs a specific ministry, regulator or constituency immediately and visibly. That asymmetry is the standard reason structural reforms fail, and it applies here in full.

The realistic assessment is that progress will be incremental and partial rather than decisive. Which means the growth-stage gap the Europe Venture Capital Report 2019 identifies should be expected to persist, narrowing gradually if at all, for the foreseeable horizon.

The productivity gap as a composition problem

A reframing occurred in 2024 that changes which remedies are relevant, and it is worth being precise about it.

The conventional framing. Europe's productivity growth has lagged, therefore European firms are less efficient, therefore the remedy is to make firms more efficient — through labour market flexibility, reduced regulation, or investment incentives.

The composition framing. The aggregate gap is substantially attributable to sector composition rather than to within-sector efficiency. Specifically, the sectors that drove productivity growth elsewhere over the period — large-scale technology platforms and the industries built on them — are under-represented in Europe.

Why the distinction matters enormously for remedies:

• If firms are inefficient, the remedy is to improve firm-level performance across the economy.
• If the composition is different, the remedy is to grow the missing sector — which is a company formation and scaling question, not an efficiency question.

The evidence points substantially at composition. European firms within a given sector are not systematically less productive than their counterparts elsewhere. The aggregate gap arises because the high-productivity-growth sector is smaller.

And that connects directly to everything else in this sequence. The missing sector is large technology companies. Europe founds technology companies and does not scale them, per the 2019 report, because of the growth-stage capital gap, which is caused by the LP chain, which is caused by rules.

The productivity gap, the growth-stage capital gap and the capital markets question are the same problem observed at three different levels of aggregation. That is why the 2024 reframing matters — it connected them.

The corollary is uncomfortable. If the gap is compositional, then remedies aimed at firm-level efficiency — the traditional structural reform agenda — address the wrong variable. The relevant intervention is whatever lets European companies scale, which is the capital question, which is political.

What became explicit about the regulatory trade-off

The Europe Investment Report 2018 describes a trade-off that was operating and unstated: protection and company formation conflict at the margin, through compliance cost as a fixed cost and through the constraints on data-dependent models.

2024 made it explicit. The competitiveness frame required acknowledging that regulatory burden has a cost in company formation, which had previously been an argument made by industry and treated as self-interested.

Why acknowledging a trade-off is genuine progress:

• It permits a choice. A trade-off that is denied cannot be optimised, because any proposal to move along it is characterised as abandoning one of the objectives.
• It permits differentiation. Once the cost is acknowledged, it becomes possible to apply requirements proportionately — lighter for small firms, heavier for large ones — which directly addresses the fixed-cost entry barrier the 2018 report identifies.
• It makes the cost measurable, which allows the trade-off to be assessed rather than asserted.

What it does not do is resolve it. The protections have real value and real constituencies. A trade-off acknowledged is a trade-off that can be argued about, which is better than one that cannot and is not the same as one that has been settled.

For investors, the practical implication is that the regulatory environment for European companies became a genuine policy variable in 2024 rather than a fixed parameter. That cuts both ways: it could ease, and the direction is a political outcome rather than a technocratic one — which means it should be modelled as a scenario rather than as a trend.

Why structural reforms fail, specifically

The diffuse-benefit concentrated-cost asymmetry is the standard explanation for reform failure, and it is worth working through for this case because it identifies which reforms are plausible and which are not.

The general structure. A reform produces a small benefit spread across a large population and a large cost concentrated on a small one. The beneficiaries are individually indifferent and collectively unorganised. The bearers of the cost are individually motivated and easily organised. The political economy therefore favours the status quo regardless of the aggregate arithmetic.

Applied to European capital markets:

• The benefit — a deeper capital market, more available growth capital, more European companies reaching scale — accrues diffusely to future companies, future employees and the general economy. None of these constituencies exists yet in an organised form, which is the sharpest version of the problem: the beneficiaries are largely companies that have not been founded.
• The cost — a national regulator ceding supervisory authority, a finance ministry ceding tax competence, a national exchange losing listings to a consolidated venue — falls on identifiable institutions with existing staff, budgets and political representation.

This predicts which reforms are achievable:

• Reforms where the cost is also diffuse are plausible. Adjusting a prudential capital charge imposes a cost on nobody in particular; it changes a calculation.
• Reforms where the cost is concentrated on an institution are difficult. Transferring supervision, harmonising insolvency, or consolidating exchanges each has a specific loser.
• Reforms requiring unanimity are hardest, because a single member with a concentrated cost can block regardless of the aggregate case. Taxation falls here.

The ranking that follows — prudential capital treatment as the most tractable, taxation and supervision as the least — is the same ranking the Europe Investment Outlook 2026 arrives at, and it is derived from political economy rather than from any judgement about which reform would help most.

The reform that would help most and the reform that can pass are different reforms. Knowing which is which is more useful than knowing which is best.

What an allocator could act on

Update on recognition, do not underwrite on it. An official diagnosis raises the probability of structural change from very low to low over a multi-year horizon. That is a genuine update and it is not a basis for a position.

Distinguish technical obstacles from political ones. A technical obstacle is removed by expert agreement. A political one requires a member state to cede a competence where the benefit is diffuse and the cost concentrated. The capital markets obstacles are almost entirely the second kind, and the decade-plus history is the relevant base rate.

Assess the productivity gap as compositional. European firms within a sector are broadly competitive; the aggregate gap reflects a missing sector. That means firm-efficiency remedies address the wrong variable and scaling capital addresses the right one.

Treat the regulatory environment as a scenario variable. It became a live policy question in 2024 rather than a fixed parameter. Proportionate application by firm size would directly reduce the entry barrier the 2018 report identifies, and its likelihood is a political judgement.

Continue watching LP allocation as the indicator that matters. Recognition changes nothing until insurer capital treatment, pension architecture or public anchor capital at growth scale changes. Invest Europe's LP-type breakdown remains the series that would show it, and it is free and annual.

Assume the growth-stage gap persists. Four years of ecosystem improvement did not close it and one year of official recognition will not either. Any European growth model should still assume a US-led round, an early sale, or slower revenue-funded growth.

What 2024 established for Europe

• The diagnosis became official, moving structural constraints from specialist analysis into the central policy frame.
• Recognition was shown to be necessary and far from sufficient, because the obstacles are national competences rather than technical standards.
• The capital markets question was clarified as political, with the diffuse-benefit concentrated-cost asymmetry that makes structural reform hard.
• The productivity gap was reframed as compositional, connecting it to the growth-stage capital gap and pointing at different remedies.
• The regulatory trade-off became explicit, which permits proportionate application and makes the environment a scenario variable rather than a fixed parameter.